Healthcare technology connecting providers, payers, and life sciences
Veradigm is a healthcare technology company providing data, analytics, and software solutions for providers, payers, and life sciences.
AI Panel Score
6 AI reviews
Reviewed
Facts checked against veradigm.com
AI Editor ApprovedApproved and published by our AI Editor-in-Chief after full panel analysis.Veradigm's solutions are used by medical practices to manage clinical and administrative operations, including electronic health records, practice management systems, and patient engagement tools. Health plans and payers use Veradigm's analytics products to manage risk adjustment, quality reporting, and pharmacy programs, while life sciences companies use its platforms to support research and analyze real-world evidence. Users typically access these tools through web-based platforms integrated into daily practice or organizational workflows, such as submitting insurance claims, tracking quality metrics, or analyzing patient outcomes data.
Several products have been consolidated into the Veradigm portfolio following acquisitions. Koha Health now operates within Veradigm, providing staffing support, medical coding, and claims submission services. Former Pulse8 solutions, including Calcul8 and Qualit8, are now part of Veradigm Payer Analytics, offering visibility into risk adjustment, quality management, and pharmacy program performance. Babel Health's risk adjustment submission workflow has also been folded into Veradigm Payer Analytics, and the Evalytica platform now operates as the Veradigm Real-World Evidence Analytics Platform, a self-service tool for analyzing real-world healthcare data.
Incorporates artificial intelligence technologies within the Veradigm Network to provide advanced data-driven insights.
Delivers reporting capabilities for staff management, coding, and claims processes as part of the Koha Health integration.
Helps payers analyze and report on quality programs to support high-quality, cost-effective patient care.
Offers visibility into Risk Adjustment, Quality Management, and Pharmacy programs through solutions like Calcul8 and Qualit8.
A self-service analytic platform (formerly Evalytica) that enables life sciences research and analysis of real-world data.
Streamlines workflows, ensures medical coding accuracy, and handles insurance claims submission to improve financial performance.
Provides an end-to-end submissions solution for regional health plans and payers, combining former Babel Health capabilities.
Supports engagement between payers and providers as part of the payer analytics suite.
Provides digital patient record-keeping for medical practices as part of the Veradigm provider technology suite.
Tools carried over from Allscripts that help practices communicate with and engage patients.
Supports administrative and operational functions for independent medical practices to run efficiently.
Connects Veradigm's solutions with external partners, data, and AI technologies to support clinical, financial, and research workflows.
For individual prescribers who want a standalone e-prescribing solution, priced per prescriber.
For small to mid-size ambulatory practices needing a full EHR and practice management platform, priced per provider with a required annual commitment.
For mid-to-large ambulatory practices, health systems, and payer organizations needing custom EHR, revenue cycle, network, and data solutions; requires contacting Veradigm sales for a tailored quote.
A rollup of six acquisitions selling stability to independent practices, not innovation.
“Veradigm bundles Practice Fusion, Koha Health, Pulse8, and Babel Health into one portfolio. That's a lot of stitching for a board to underwrite with confidence.”
Practice Fusion EHR at $199/month, ePrescribe at $59. Priced like commodity software because it is commodity software — EHR and revenue cycle tools are mature, crowded categories against Epic, athenahealth, and Modernizing Medicine.
Two things stand out. One: this is a rollup — Koha Health, Pulse8, Babel Health, Evalytica all folded in since 2018, which means integration risk, not product risk. Two: Veradigm had a public accounting scandal and delisted from Nasdaq in 2024. That's not a rumor, that's a fact the board will ask about.
The payer analytics stack (Calcul8, Qualit8, RA submission workflows) is real infrastructure health plans need. But buying from a company mid-reorganization, with no public pricing transparency past the entry tier, is a harder sell than picking athenahealth.
Independent practices already run on this or similar tools; it's parity, not advantage, versus athenahealth.
Board members who read financial news will ask about the delisting before they ask about features.
Practice Fusion is a known, deployable product at $199/month with scheduling and claims submission included day one.
Solves table-stakes EHR and revenue cycle needs, doesn't advance a differentiated care or data strategy.
A 2024 Nasdaq delisting and a restatement of its 2022 financials are real red flags regardless of underlying revenue.
Small independent practices that just need certified EHR and e-prescribing at a fixed monthly price.
Skip it if your board will ask hard questions about vendor financial stability.
A consolidation play, not a clinical platform — assembled from acquisitions, not built around a care model.
“Veradigm has the breadth to touch every corner of the revenue and quality cycle, but the roadmap reads like an org chart of M&A, not a clinical vision. That's fine for billing. It's a liability for anything touching patient safety.”
Koha Health, Pulse8's Calcul8 and Qualit8, Babel Health, Evalytica — four acquisitions stitched into one 'Network', with Evalytica on the books since 2018. As a CMO I read that as integration debt, not synergy. Each of those platforms had its own data model and validation logic before Veradigm absorbed it.
Domain fit is split. Practice Fusion EHR at $199/month suits a small ambulatory practice fine for scheduling and e-prescribing, similar to what athenahealth or eClinicalWorks offer at that tier. But 'AI-Powered Insights' with no cited validation study, no clinical evidence trail, and no FDA/CDS transparency that I could find is a governance problem I can't sign off on for anything touching diagnosis or risk stratification.
Three years out: you're locked into a vendor whose core competency is claims and risk-adjustment analytics, not clinical decision support. Fine for revenue cycle. Not where I'd bet care quality infrastructure.
Sits between athenahealth-style EHR vendors and payer analytics firms, without a clear category-leading edge in either.
Matches how independent practices run billing and scheduling, less so how clinicians make bedside decisions.
Veradigm Connect's open APIs and App Expo give real third-party extensibility, similar to Epic's App Orchard model.
Four stitched-together acquisitions (Koha, Pulse8, Babel, Evalytica) create integration and data-lineage risk over time.
Deep on RCM and payer analytics (Payerpath, Payer Analytics); thin, unvalidated AI claims for clinical insight.
Independent practices or regional payers needing consolidated billing, risk-adjustment, and e-prescribing under one vendor.
You need clinically validated AI decision support with transparent evidence, not administrative automation.
$59 ePrescribe and the $199 EHR are real. Everything above them is a sales call.
“Two tiers priced, one tier hidden behind sales. That third tier is where actual practices and payers end up.”
$59/month for solo ePrescribe. $199/month per provider for the Practice Fusion EHR tier on a required annual commitment — scheduling, e-prescribing and claims submission bundled in, full billing services quoted separately. Fine, transparent, procurement-friendly at that size.
But mid-to-large practices, health systems, payers — the actual Veradigm Network buyers — hit 'Contact Sales.' No published number for Payerpath, Payer Analytics, or RWE Analytics. That's where this company makes its money, and it's also where your 3-year TCO becomes a guess.
50-provider practice on the $199 tier: $199 × 50 × 12 = $119,400/year, before implementation, data migration from legacy Allscripts systems, or clearinghouse fees. Compare to athenahealth or Epic's ambulatory suite — similar sales-call opacity, similar integration tax. No overage rates published anywhere. No stated contract term or renewal window on the enterprise side. Procurement should budget for a negotiation, not a checkout.
Monthly billing on entry tiers is clean, though the EHR tier requires an annual commitment; enterprise onboarding friction is unstated.
No published term length or renewal terms for enterprise contracts.
Two tiers listed at $59 and $199, but enterprise/payer pricing is sales-call only.
Quality reporting and risk adjustment metrics are measurable, but no benchmark data provided.
No migration, integration, or clearinghouse fee data for the tier most health systems actually need.
Solo prescribers or small practices needing e-prescribing and EHR at published, monthly pricing.
You need payer analytics or enterprise EHR and want price certainty before a sales call.
Deep portfolio, but stitched together from six acquisitions you'll feel in the seams
“Practice Fusion EHR at $199/month covers scheduling, telehealth, and e-prescribing for small ambulatory practices. The bigger Veradigm Network is powerful on paper but shows its acquisition scars once you're actually charting.”
Koha Health for coding, Pulse8's Calcul8/Qualit8 for payer analytics, Babel Health for risk adjustment submission — all folded into one portfolio. Good for a sales deck, rougher for a biller who has to know which module owns which workflow on a Tuesday afternoon. That's the day-3 problem: a string of acquisitions under one brand name means inconsistent UI patterns across EHR, RCM, and payer tools.
Compared to Epic or athenahealth, Veradigm's strength is pricing transparency at the low end — $59/month for standalone ePrescribe, $199 for full EHR — but enterprise and payer tiers drop into 'contact sales,' which means no clean quote for anyone comparing options at 4pm before a budget meeting.
AI Patient Scheduling and eChart Courier automation are genuinely useful daily-friction reducers if they work as described. Documentation holds up for onboarding: Practice Fusion keeps a 24-hour knowledge base of video tutorials and step-by-step guides, and API documentation sits in the Veradigm developer portal. Practice Fusion also posts release notes every two weeks in its help center, so tracking what changed between releases takes a bookmark, not guesswork.
Acquisition-stitched modules (Koha, Pulse8, Babel Health) suggest inconsistent UX once past the demo.
Practice Fusion's 24-hour knowledge base and the API documentation in Veradigm's developer portal cover onboarding and integration, and Practice Fusion posts release notes every two weeks in its help center.
Enterprise/payer tiers require sales contact, no self-serve quote, slowing procurement for busy practices.
Veradigm Network and RWE Analytics Platform (formerly Evalytica) show real depth for payer and life sciences power users.
Practice Fusion EHR bundles scheduling, telehealth, e-prescribing into one workflow at $199/month.
Small to mid-size independent practices wanting an affordable, bundled EHR and e-prescribing solution.
You need a single consistent interface across payer analytics, RCM, and clinical workflows without training staff on multiple legacy systems.
Veradigm sells to health systems, but the person closing charts at 5pm gets Practice Fusion.
“Practice Fusion is the part of Veradigm regular people actually live in, and it's settled into unflashy, dependable web software. Veradigm Connect's open APIs help round it out, but browser-only tablet charting and a sponsored-alerts past leave marks.”
Nobody loves their EHR. The realistic goal is one you stop noticing, and Veradigm's everyday piece — Practice Fusion — mostly clears that bar. Charting, scheduling, e-prescribing in one browser tab. Free and ad-supported for years, until Allscripts paid $100 million in 2018 and the ads became a subscription.
Veradigm Connect is the sleeper here — open APIs plus an App Expo of certified apps, so a small practice can add what's missing without an integrator. But trust has a scar: Practice Fusion paid $145 million in 2020 to settle DOJ claims that an opioid maker paid to shape its in-chart prescribing alerts. The pop-ups in the workflow were once for sale.
Mobile is the other tell — Practice Fusion charts on an iPad through a touch-optimized browser version rather than a native app, while DrChrono built its whole EHR around the iPad. The company spent 2024 shopping itself before choosing to stay standalone. In an exam room, familiar beats exciting. Barely.
Practice Fusion keeps charting, scheduling, and e-prescribing in one tab, though post-acquisition seams show across the wider suite.
Practice Fusion's simplicity is the pitch — a new front-desk hire learns it fast, with complexity deferred to the payer tools.
iPad and tablet charting runs in the browser with the full desktop feature set, but clinicians moving between sites will still feel the missing native app.
A published self-serve tier lets a small practice start without a sales cycle, while enterprise buyers get a quote process instead.
A charting stack running continuously since the free-EHR era feels settled, and a public status page plus release notes every two weeks back that up.
Small independent practices who want simple web-based charting at a published monthly price.
Clinicians who want a native mobile app rather than charting in a tablet browser.
Six product names, one roadmap question mark: is this integration or accumulation?
“Veradigm is Allscripts wearing a new name, stitched together from at least five acquisitions — Koha Health, Pulse8, Babel Health, Evalytica. That's not automatically bad. It's a lot to migrate off of if the parent company stumbles.”
Three tells before the pricing page. One: Calcul8, Qualit8, eChart Courier, Payerpath — four product names in one portfolio, no unified naming, screams post-merger sprawl. Two: the API documentation lives in a separate developer portal, and the release notes live in yet another place, Practice Fusion's help center. Three: 'AI-Powered Insights' with zero specifics on model or data source — the kind of phrase every EHR vendor slaps on now, from Epic to athenahealth.
Pricing is oddly transparent for enterprise healthcare — $59/month ePrescribe, $199/month full EHR — then drops to 'contact sales' the moment payers or health systems show up. Normal for the category. Still a tell on where the real revenue lives.
Track record concern: Veradigm is Allscripts rebranded, carrying legacy patient engagement tools forward. That's continuity, not innovation. Exit portability is the real worry — once your claims, coding, and risk adjustment data live inside Payerpath and Koha Health, untangling that in 18 months is not a weekend project.
Against Epic and athenahealth the edge is breadth across provider and payer work rather than depth in either.
Claims, coding and risk adjustment history sit inside Payerpath, so leaving is a data-lineage project measured in quarters.
Practice management, e-prescribing and clearinghouse revenue is sticky by nature, but whether one roadmap emerges from a portfolio assembled this way is still open.
"AI-Powered Insights" is the phrase every EHR vendor now uses, and Veradigm attaches no named model or data source to it.
The Allscripts customer base plus Koha, Pulse8, Babel and Evalytica landing in named product lines is continuity; none of it is evidence of new invention.
Practices that want a long-running vendor's continuity more than a new roadmap.
Anyone who may need their claims and coding data back out inside eighteen months.
Common questions answered by our AI research team
Veradigm ePrescribe is an affordable, certified e-Prescribing solution that includes support for controlled substances.
Yes. Veradigm offers AI Patient Scheduling to automate and optimize patient scheduling with artificial intelligence.
Yes. Veradigm Connect lets health tech solutions connect with physicians and patients through open APIs, and the App Expo features certified applications and devices built on those APIs for provider practices.
eChart Courier automates electronic chart retrieval, saving time, reducing costs, and increasing efficiency for the medical chart retrieval process.
Yes. Veradigm Payerpath is an all-in-one revenue cycle management solution featuring a top-tier clearinghouse for claims and EDI, alongside risk adjustment support.
Who Veradigm competes with, and how each one differs
athenahealth competes directly in ambulatory EHR and practice management with a cloud-native, single-instance platform and a network-effect pricing model, versus Veradigm's licensed/subscription EHR business plus separate payer and life-sciences data segments.
Komodo Health sells real-world healthcare data and analytics (its "Healthcare Map") to life sciences and payer clients, competing for the same budgets as Veradigm's Life Science segment, but aggregates claims and multi-source data rather than capturing it at the point of care through an owned EHR.
IQVIA is a far larger (~$15B revenue) life-sciences data, technology and clinical-research company whose real-world-data offerings compete with Veradigm's EHR-derived data business, backed by broader commercial reach and a global research/consulting arm Veradigm does not have.
Flatiron Health, owned by Roche, is the market leader in oncology-specific real-world data drawn from its own oncology EHR and clinic network, competing narrowly with Veradigm's life-sciences data business in cancer analytics rather than across Veradigm's broader ambulatory and payer scope.
Veradigm is a Chicago-based healthcare technology company providing electronic health records, data, and clinical workflow solutions to providers, payers, and life sciences firms.
